Navigation Links
Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results
Date:5/4/2011

002 White Paper and related implementation guidance.  A reconciliation of net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders in accordance with United States generally accepted accounting principles ("GAAP") to FFO attributable to Alexandria Real Estate Equities, Inc.'s common stockholders is included in the financial information accompanying this press release.  The primary reconciling items between GAAP net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders and FFO attributable to Alexandria Real Estate Equities, Inc.'s common stockholders is depreciation and amortization expense and gain on sales of property. Depreciation and amortization expense for the three months ended March 31, 2011 and 2010 was $36,707,000 and $29,738,000, respectively.  Net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders for the first quarter of 2011 was $24,365,000, or $0.44 per share (diluted), compared to net income attributable to Alexandria Real Estate Equities, Inc.'s common stockholders of $20,542,000, or $0.47 per share (diluted), for the first quarter of 2010.  

The following table summarizes the significant items that impacted FFO (diluted) during each period presented (dollars in thousands, except per share data):Three Months Ended3/31/1112/31/109/30/106/30/103/31/10FFO attributable to Alexandria Real Estate Equities, Inc.'s common stockholders – numerator for FFO per share (diluted), as reported$
,636$
58,474$
53,862$
9,840$
53,980Loss on early extinguishment of debt2,4952,3721,30041,496-Assumed conversion of 8% unsecured convertible notes (1)---3,560-Impact of unvested restricted stock awards(21)(20)(11)(333)-FFO (diluted), as adjusted$
3,110$
,826$
55,151$
54,563$
53,980Weighted average shares of common stock outstanding for calculating FFO per share attributable to Alexandria Real Estate Equities, Inc.'s
'/>"/>

SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community
2. Clet Niyikiza, Merrimack's Executive Vice President of Development, to Present at BioVisionAlexandria 2010
3. Alexandria Real Estate Equities, Inc. Provides Update
4. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
5. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
6. Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock
7. Deals keep Coming in Medical real Estate
8. Millions Flowing into Medical Real Estate
9. Life Sciences Real Estate Outperforming Other Sectors
10. Miami Beach Real Estate Attorney Opens Miami Real Estate Brokerage for International Luxury Miami Beach Condo Buyers From Distressed Sellers
11. Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Brady (NYSE:BRC), a global leader in product ... align chemical container labeling with OSHA’s updated Hazard Communication (HazCom) Standard and the ... of an accurate label, and pictogram uses and meanings. , “With changes to ...
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  Pfenex ... quarter 2015 financial results will be released on Thursday, ... 8:30 am Eastern Time, Pfenex management will host a ... a business update.  A press release outlining the financial ... to the call. Please call 1-866-376-8058 (US) ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company, is pleased to announce that ... injector (RCI-02) have been locked.  Prototypes for industrial ... prepare for an application for CE mark clearance ... in 2016. (Photo: ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences ... recruitment services. The core expertise of PRC Clinical is focused on Clinical Trial ...
Breaking Biology Technology:Brady Announces a New GHS Label Guide 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3
... , , , ... , , , Transcriptor Reverse ... , , , , ... gene expression profiling experiment. The,improved reliability of commercially available microarray,platforms has shifted the ...
... , , ... , , The following protocol ... research studies,it enables detection of the expression of rare mRNAs in,the ... in normal human coronary arteries, and of,interleukin 6 [IL6] and glycoprotein ...
... , , , ... Over the past decade, many organisms have been the,subject of large-scale genome ... functional analysis. Knowledge of tissues and cells,that express particular genes is key to ... , , , Microarrays and similar high-throughput ...
Cached Biology Technology:Increased Sensitivity in Microarray Analysis 2Increased Sensitivity in Microarray Analysis 3Detection of mRNAs on Cryosections of the,Cardiovascular System Using DIG-Labeled RNA Probes 2Detection of mRNAs on Cryosections of the,Cardiovascular System Using DIG-Labeled RNA Probes 3Detection of mRNAs on Cryosections of the,Cardiovascular System Using DIG-Labeled RNA Probes 4Detection of mRNAs on Cryosections of the,Cardiovascular System Using DIG-Labeled RNA Probes 5Detection of mRNAs on Cryosections of the,Cardiovascular System Using DIG-Labeled RNA Probes 6The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 2The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 3The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 4The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 5The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 6
(Date:7/31/2015)... , Chine, 31 juillet 2015 ... www.icg-10.org ) sera organisée par le BGI ... Shenzhen en Chine. ... Depuis son inauguration en 2006, l,ICG est devenue ... dans le domaine des « omiques » et c,est aussi ...
(Date:7/31/2015)... SHENZHEN, China , 31. Juli 2015 Die ... ) wird von BGI veranstaltet und findet vom ... Shenzhen, China , statt. ... Jubiläum. Seit ihrem Start 2006 ist die ICG ... Bereich „omik" geworden. Sie ist eines der dynamischsten, ...
(Date:7/31/2015)... 2015 The 10 th International Conference on ... October 22-25, 2015, in Shenzhen , ... celebrating its 10 th anniversary this year. Since its inauguration ... influential annual meetings in the ,omics, fields, and is one ... ICG-10 focuses on recent breakthroughs and advances in ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
... Iowa State University, ConocoPhillips and the U.S. ... have reached a Memorandum of Understanding to identify ... mid- and long-term. The collaboration will bring three ... most efficient and cost-effective methods for making liquid ...
... faculty in the Virginia-Maryland Regional College of Veterinary ... awarded funding from the Wake Forest University Translational ... brain tumors in dogs, cats and humans. ... Department of Small Animal Clinical Sciences (DSACS), is ...
... One of the earliest general anaesthetics to be used by ... thats puzzled doctors for more than 150 years how ... serendipity made by Leeds University PhD student Dr Yahya Bahnasi, ... general anaesthesia and offer the opportunity to design new ...
Cached Biology News:Iowa State, ConocoPhillips and National Renewable Energy Lab to cooperate on biofuels research 2Veterinary college researcher studying brain tumors in people and animals 2Veterinary college researcher studying brain tumors in people and animals 3Chloroform provides clue to 150 year old medical puzzle 2
Mouse monoclonal antibody to RAD51L3 - RAD51-like 3 (S. cerevisiae)...
ACS Reagent Grade C 19 H 14 O 5 S Formula Weight: 354.38 PRODUCT SPECIFICATIONS Form: Rust/red crystalline powder Clarity of Solution: Passes test Visual Transition Interval: pH 6.8 - Yellow pH 8.2...
Mouse monoclonal [34B12] to Nop5p + Nop58p - Nucleolar Marker ( Abpromise for all tested applications)....
... Mouse Anti Nop1p/Fibrillarin (monoclonal) ... a nucleolar protein of bakers yeast, ... protein is essential for yeast viability ... The human homologue of Nop1p is ...
Biology Products: